Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 10.64% | -6.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.64% | -6.20% | |||
| Cost of Revenue | 3.90% | -1.31% | |||
| Gross Profit | 13.47% | -8.12% | |||
| SG&A Expenses | 1.77% | -7.61% | |||
| Depreciation & Amortization | -0.07% | 4.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.96% | -3.75% | |||
| Operating Income | 52.40% | -16.45% | |||
| Income Before Tax | 29.73% | -20.74% | |||
| Income Tax Expenses | -339.72% | -15.70% | |||
| Earnings from Continuing Operations | 157.64% | -22.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -150.00% | 0.00% | |||
| Net Income | 157.65% | -22.38% | |||
| EBIT | 52.40% | -16.45% | |||
| EBITDA | 29.12% | -9.31% | |||
| EPS Basic | 158.91% | -22.49% | |||
| Normalized Basic EPS | 47.02% | -17.48% | |||
| EPS Diluted | 160.39% | -23.00% | |||
| Normalized Diluted EPS | 47.31% | -17.40% | |||
| Average Basic Shares Outstanding | -0.48% | 0.14% | |||
| Average Diluted Shares Outstanding | -0.67% | 0.05% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.61% | 0.28% | |||